Logo image of ZS

ZSCALER INC (ZS) Stock Fundamental Analysis

USA - NASDAQ:ZS - US98980G1022 - Common Stock

292.905 USD
-0.21 (-0.07%)
Last: 11/19/2025, 9:47:08 AM
Fundamental Rating

4

ZS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. The financial health of ZS is average, but there are quite some concerns on its profitability. ZS is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ZS was profitable.
ZS had a positive operating cash flow in the past year.
In the past 5 years ZS always reported negative net income.
Each year in the past 5 years ZS had a positive operating cash flow.
ZS Yearly Net Income VS EBIT VS OCF VS FCFZS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

ZS has a Return On Assets of -0.65%. This is comparable to the rest of the industry: ZS outperforms 55.52% of its industry peers.
ZS has a Return On Equity (-2.31%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.65%
ROE -2.31%
ROIC N/A
ROA(3y)-2.49%
ROA(5y)-6.57%
ROE(3y)-11.58%
ROE(5y)-30.47%
ROIC(3y)N/A
ROIC(5y)N/A
ZS Yearly ROA, ROE, ROICZS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

The Gross Margin of ZS (76.87%) is better than 72.60% of its industry peers.
In the last couple of years the Gross Margin of ZS has remained more or less at the same level.
ZS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y-0.23%
ZS Yearly Profit, Operating, Gross MarginsZS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

6

2. Health

2.1 Basic Checks

ZS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZS has been increased compared to 1 year ago.
Compared to 5 years ago, ZS has more shares outstanding
The debt/assets ratio for ZS is higher compared to a year ago.
ZS Yearly Shares OutstandingZS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ZS Yearly Total Debt VS Total AssetsZS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

ZS has an Altman-Z score of 6.58. This indicates that ZS is financially healthy and has little risk of bankruptcy at the moment.
ZS has a Altman-Z score of 6.58. This is in the better half of the industry: ZS outperforms 77.94% of its industry peers.
ZS has a debt to FCF ratio of 2.34. This is a good value and a sign of high solvency as ZS would need 2.34 years to pay back of all of its debts.
ZS has a better Debt to FCF ratio (2.34) than 67.26% of its industry peers.
ZS has a Debt/Equity ratio of 0.95. This is a neutral value indicating ZS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.95, ZS is not doing good in the industry: 73.31% of the companies in the same industry are doing better.
Although ZS does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 2.34
Altman-Z 6.58
ROIC/WACCN/A
WACC10.9%
ZS Yearly LT Debt VS Equity VS FCFZS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

ZS has a Current Ratio of 2.01. This indicates that ZS is financially healthy and has no problem in meeting its short term obligations.
ZS has a Current ratio (2.01) which is comparable to the rest of the industry.
ZS has a Quick Ratio of 2.01. This indicates that ZS is financially healthy and has no problem in meeting its short term obligations.
ZS has a better Quick ratio (2.01) than 60.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 2.01
ZS Yearly Current Assets VS Current LiabilitesZS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

8

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.82% over the past year.
The Earnings Per Share has been growing by 68.71% on average over the past years. This is a very strong growth
The Revenue has grown by 23.31% in the past year. This is a very strong growth!
The Revenue has been growing by 44.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2.82%
EPS 3Y68.14%
EPS 5Y68.71%
EPS Q2Q%1.14%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y34.82%
Revenue growth 5Y44.03%
Sales Q2Q%21.31%

3.2 Future

The Earnings Per Share is expected to grow by 21.82% on average over the next years. This is a very strong growth
ZS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.88% yearly.
EPS Next Y15.58%
EPS Next 2Y17.95%
EPS Next 3Y19.75%
EPS Next 5Y21.82%
Revenue Next Year23.29%
Revenue Next 2Y21.27%
Revenue Next 3Y20.75%
Revenue Next 5Y19.88%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ZS Yearly Revenue VS EstimatesZS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
ZS Yearly EPS VS EstimatesZS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 10 15

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 89.30, which means the current valuation is very expensive for ZS.
ZS's Price/Earnings ratio is in line with the industry average.
ZS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.51.
The Price/Forward Earnings ratio is 77.27, which means the current valuation is very expensive for ZS.
ZS's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of ZS to the average of the S&P500 Index (34.98), we can say ZS is valued expensively.
Industry RankSector Rank
PE 89.3
Fwd PE 77.27
ZS Price Earnings VS Forward Price EarningsZS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

ZS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 63.81
EV/EBITDA N/A
ZS Per share dataZS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ZS's earnings are expected to grow with 19.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.73
PEG (5Y)1.3
EPS Next 2Y17.95%
EPS Next 3Y19.75%

0

5. Dividend

5.1 Amount

ZS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZSCALER INC

NASDAQ:ZS (11/19/2025, 9:47:08 AM)

292.905

-0.21 (-0.07%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-02 2025-09-02/amc
Earnings (Next)11-25 2025-11-25/amc
Inst Owners56.62%
Inst Owner Change63.64%
Ins Owners35.96%
Ins Owner Change5.71%
Market Cap46.37B
Revenue(TTM)2.67B
Net Income(TTM)-41.48M
Analysts80.71
Price Target331.67 (13.23%)
Short Float %5.87%
Short Ratio4.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.32%
Min EPS beat(2)8.25%
Max EPS beat(2)8.39%
EPS beat(4)4
Avg EPS beat(4)11.04%
Min EPS beat(4)8.25%
Max EPS beat(4)18.11%
EPS beat(8)8
Avg EPS beat(8)19.74%
EPS beat(12)12
Avg EPS beat(12)18.67%
EPS beat(16)16
Avg EPS beat(16)20.39%
Revenue beat(2)0
Avg Revenue beat(2)-1.22%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)-1.21%
Revenue beat(4)1
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-1.22%
Max Revenue beat(4)0.57%
Revenue beat(8)5
Avg Revenue beat(8)0.13%
Revenue beat(12)8
Avg Revenue beat(12)0.42%
Revenue beat(16)12
Avg Revenue beat(16)1.18%
PT rev (1m)-0.17%
PT rev (3m)2.68%
EPS NQ rev (1m)0.06%
EPS NQ rev (3m)2.31%
EPS NY rev (1m)0.01%
EPS NY rev (3m)0.48%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)3.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.33%
Valuation
Industry RankSector Rank
PE 89.3
Fwd PE 77.27
P/S 17.35
P/FCF 63.81
P/OCF 47.68
P/B 25.77
P/tB 34.75
EV/EBITDA N/A
EPS(TTM)3.28
EY1.12%
EPS(NY)3.79
Fwd EY1.29%
FCF(TTM)4.59
FCFY1.57%
OCF(TTM)6.14
OCFY2.1%
SpS16.89
BVpS11.37
TBVpS8.43
PEG (NY)5.73
PEG (5Y)1.3
Graham Number28.96
Profitability
Industry RankSector Rank
ROA -0.65%
ROE -2.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.87%
FCFM 27.19%
ROA(3y)-2.49%
ROA(5y)-6.57%
ROE(3y)-11.58%
ROE(5y)-30.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y-0.23%
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 2.34
Debt/EBITDA N/A
Cap/Depr 202.8%
Cap/Sales 9.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.01
Quick Ratio 2.01
Altman-Z 6.58
F-Score4
WACC10.9%
ROIC/WACCN/A
Cap/Depr(3y)212%
Cap/Depr(5y)195.75%
Cap/Sales(3y)8.71%
Cap/Sales(5y)8.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.82%
EPS 3Y68.14%
EPS 5Y68.71%
EPS Q2Q%1.14%
EPS Next Y15.58%
EPS Next 2Y17.95%
EPS Next 3Y19.75%
EPS Next 5Y21.82%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y34.82%
Revenue growth 5Y44.03%
Sales Q2Q%21.31%
Revenue Next Year23.29%
Revenue Next 2Y21.27%
Revenue Next 3Y20.75%
Revenue Next 5Y19.88%
EBIT growth 1Y-0.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.15%
EBIT Next 3Y33.84%
EBIT Next 5YN/A
FCF growth 1Y24.23%
FCF growth 3Y46.46%
FCF growth 5Y92.49%
OCF growth 1Y24.7%
OCF growth 3Y44.56%
OCF growth 5Y65.09%

ZSCALER INC / ZS FAQ

Can you provide the ChartMill fundamental rating for ZSCALER INC?

ChartMill assigns a fundamental rating of 4 / 10 to ZS.


What is the valuation status for ZS stock?

ChartMill assigns a valuation rating of 1 / 10 to ZSCALER INC (ZS). This can be considered as Overvalued.


How profitable is ZSCALER INC (ZS) stock?

ZSCALER INC (ZS) has a profitability rating of 3 / 10.


What is the valuation of ZSCALER INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ZSCALER INC (ZS) is 89.3 and the Price/Book (PB) ratio is 25.77.


How financially healthy is ZSCALER INC?

The financial health rating of ZSCALER INC (ZS) is 6 / 10.